However, it is also possible that CD34-positive tumors are derived from CD34+ SFCs while CD34-negative tumors have completely different origins; if such is the case, CD34-positive tumors could be considered a new tumor entity derived from CD34+ SFCs that are associated with better prognoses. The gene discussed is CD34; the disease is neoplasm.